Showing results (561-570 of 963) with videos related to
Sort By:
Pageof 97
Disability and Rehabilitation|July 24, 2025
Evaluation of an inpatient sports program to guide post-discharge physical activity participation among people with brain and spinal cord injury - a cross-sectional studyHannah Daniel, Emily A Bray, Emma M Beckman, et al.Soft Matter|December 6, 2018
Propofol adsorption at the air/water interface: a combined vibrational sum frequency spectroscopy, nuclear magnetic resonance and neutron reflectometry studyPetru Niga, Petra M Hansson-Mille, Agne Swerin, et al.Brain Impairment : a Multidisciplinary Journal of the Australian Society for the Study of Brain Impairment|January 3, 2024
Effects of wearing textured versus smooth shoe insoles for 12 weeks on gait, foot sensation and patient-reported outcomes, in people with multiple sclerosis: a randomised controlled trialAnna L Hatton, Katrina Williams, Mark D Chatfield, et al.Journal of Gastroenterology and Hepatology|March 3, 2006
Treatment of chronic hepatitis C patients with persistently normal alanine aminotransferase levels with the combination of peginterferon alpha-2a (40 kDa) plus ribavirin: impact on health-related quality of lifeSanjeev Arora, Christopher O'Brien, Stefan Zeuzem, et al.Rheumatology Advances in Practice|April 7, 2023
Cocaine-induced granulomatosis with polyangiitis-an under-recognized conditionCharn Gill, Joseph Sturman, Leyla Ozbek, et al.Journal of Colloid and Interface Science|May 8, 2018
Interactions between model cell membranes and the neuroactive drug propofolPetru Niga, Petra M Hansson-Mille, Agne Swerin, et al.The Lancet. Gastroenterology & Hepatology|July 8, 2021
Safety, pharmacokinetics, and antiviral activity of RO7049389, a core protein allosteric modulator, in patients with chronic hepatitis B virus infection: a multicentre, randomised, placebo-controlled, phase 1 trialMan-Fung Yuen, Xue Zhou, Edward Gane, et al.Liver International : Official Journal of the International Association for the Study of the Liver|February 27, 2022
Durability of sustained virological response to glecaprevir/pibrentasvir and resistance development: A long-term follow-up studyFred Poordad, Franco Felizarta, Betty B Yao, et al.Journal of Viral Hepatitis|January 22, 2019
Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir-containing regimen: Results from a retreatment studyPeter Ruane, Simone I Strasser, Edward J Gane, et al.The New England Journal of Medicine|December 7, 2000
Peginterferon alfa-2a in patients with chronic hepatitis CS Zeuzem, S V Feinman, J Rasenack, et al.Pageof 97